Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 4Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Genitourinary 2Breast 2Thoracic 1Plasma cell 1Other solid neoplasm 1Myeloid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Interleukin-12 Subunit p35 × Gastrointestinal × Clear all
NCT00003046 2012-07-30

Interleukin-12 in Treating Patients With Cancer in the Abdomen

M.D. Anderson Cancer Center

Phase 1 Completed
29 enrolled
GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡